Response to "key amprenavir resistance mutations counteract dramatic efficacy of darunavir in highly experienced patients"

AIDS. 2008 Jan 2;22(1):165-7. doi: 10.1097/QAD.0b013e3282f2be42.
No abstract available

Publication types

  • Letter
  • Review
  • Comment

MeSH terms

  • Carbamates / pharmacology*
  • Darunavir
  • Drug Resistance, Viral / genetics
  • Furans
  • HIV / drug effects*
  • HIV Infections / drug therapy*
  • HIV Infections / virology
  • HIV Protease Inhibitors / pharmacology*
  • HIV Protease Inhibitors / therapeutic use*
  • Humans
  • Sulfonamides / pharmacology*
  • Sulfonamides / therapeutic use*
  • Treatment Outcome

Substances

  • Carbamates
  • Furans
  • HIV Protease Inhibitors
  • Sulfonamides
  • amprenavir
  • Darunavir